L Sullivan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
L Sullivan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
A Al-Maskari
Ophthalmology Department, St James University Hospital, Beckett Street, Leeds, United Kingdom
1 shared publicationA Glenn
Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
1 shared publicationB Y Chang
Ophthalmology Department, St James University Hospital, Beckett Street, Leeds, United Kingdom
1 shared publicationC Bong
St James University Hospital, Leeds, UK
1 shared publicationC P R Williams
University Hospital of Wales, Cardiff, UK
1 shared publicationD Burton
St James University Hospital, Leeds, UK
1 shared publication
Latest Publications
- 16 July 2016
- Vol. 19 (3) , 216-8
External dacryocystorhinostomy in consultants and fellows - a comparison of the causes of failure.
Failure of primary dacryocystorhinostomy (DCR) often requires revision surgery to inspect the cause of failure and re-establish anatomic patency. This study aims to specifcally compare the anatomical causes of failure noted during revision DCR of primary external DCR (EX-DCR) and compare the difference between consultants and fellows. A retrospective review of 37 patients who underwent revision of a primary external approach DCR over a 7-year-period in a University Hospital. All primary surgery was performed by either a consultant surgeon or senior oculoplastic fellow. Details of the initial pathology prior to primary DCR and grade of operating surgeon were collected along with perioperative surgical findings. The cause of failure of the initial surgery was classified according to perioperative findings. Failure was classified as either inappropriately sized/located ostium or fibrous/membranous soft tissue obstruction of the newly created ostium. The cause of failure of the initial surgery was soft tissue obstruction in 43.3% and an inappropriately sized/located ostium in 56.7%. In those patients whose primary surgery was performed by a consultant, 73.3% were found to have a soft tissue obstruction and 26.7% were found to have an inappropriately sized/ located ostium. In contrast, if initial surgery was performed by a fellow, 22.7% were found to have a soft tissue obstruction and 77.3% an inappropriately sized/ located ostium (p =0.002). Where the primary surgeon has been a trainee there is a trend toward inadequately sized or located ostium being the most likely causative factor in failure of primary EX-DCR. Hippokratia 2015; 19 (3): 216-218.
- 16 July 2016
- Vol. 19 (3) , 216-8
External dacryocystorhinostomy in consultants and fellows - a comparison of the causes of failure.
Failure of primary dacryocystorhinostomy (DCR) often requires revision surgery to inspect the cause of failure and re-establish anatomic patency. This study aims to specifcally compare the anatomical causes of failure noted during revision DCR of primary external DCR (EX-DCR) and compare the difference between consultants and fellows. A retrospective review of 37 patients who underwent revision of a primary external approach DCR over a 7-year-period in a University Hospital. All primary surgery was performed by either a consultant surgeon or senior oculoplastic fellow. Details of the initial pathology prior to primary DCR and grade of operating surgeon were collected along with perioperative surgical findings. The cause of failure of the initial surgery was classified according to perioperative findings. Failure was classified as either inappropriately sized/located ostium or fibrous/membranous soft tissue obstruction of the newly created ostium. The cause of failure of the initial surgery was soft tissue obstruction in 43.3% and an inappropriately sized/located ostium in 56.7%. In those patients whose primary surgery was performed by a consultant, 73.3% were found to have a soft tissue obstruction and 26.7% were found to have an inappropriately sized/ located ostium. In contrast, if initial surgery was performed by a fellow, 22.7% were found to have a soft tissue obstruction and 77.3% an inappropriately sized/ located ostium (p =0.002). Where the primary surgeon has been a trainee there is a trend toward inadequately sized or located ostium being the most likely causative factor in failure of primary EX-DCR. Hippokratia 2015; 19 (3): 216-218.
- 17 January 2014
- Published by Springer Nature in Eye
- Vol. 28 (4) , 492-494
Intravitreal bevacizumab injection in unrecognised early pregnancy
The use of intravitreal vascular endothelial growth factor (VEGF) inhibitor medications has widened considerably to include indications affecting females of reproductive age. We present our experiences following intravitreal injection of bevacizumab during the first trimester of unrecognised pregnancies in four women. All our patients were inadvertently exposed to bevacizumab within the first trimester when placental growth and fetal organogenesis take place. There were three cases of pregnancy without complication and one case of complicated pregnancy in which there was a significant past obstetric history. This case series provides further insights into intravitreal injection of bevacizumab in early pregnancy. There is insufficient information to suggest that such use is safe, nor is there definitive evidence to suggest that it causes harm. We advise that ophthalmologists discuss pregnancy with women of childbearing age undergoing intraocular anti-VEGF injections. Should a woman become pregnant, counselling is needed to explain the potential risks and benefits, and the limited available data relating to the use of these agents in early pregnancy.
- 17 January 2014
- Published by Springer Nature in Eye
- Vol. 28 (4) , 492-494
Intravitreal bevacizumab injection in unrecognised early pregnancy
The use of intravitreal vascular endothelial growth factor (VEGF) inhibitor medications has widened considerably to include indications affecting females of reproductive age. We present our experiences following intravitreal injection of bevacizumab during the first trimester of unrecognised pregnancies in four women. All our patients were inadvertently exposed to bevacizumab within the first trimester when placental growth and fetal organogenesis take place. There were three cases of pregnancy without complication and one case of complicated pregnancy in which there was a significant past obstetric history. This case series provides further insights into intravitreal injection of bevacizumab in early pregnancy. There is insufficient information to suggest that such use is safe, nor is there definitive evidence to suggest that it causes harm. We advise that ophthalmologists discuss pregnancy with women of childbearing age undergoing intraocular anti-VEGF injections. Should a woman become pregnant, counselling is needed to explain the potential risks and benefits, and the limited available data relating to the use of these agents in early pregnancy.
- Open Access
- 29 November 2013
- Published by Springer Nature in Eye
- Vol. 28 (2) , 239
Re: Adherence to NICE guidelines for new glaucoma referrals
- 29 November 2013
- Published by Springer Nature in Eye
- Vol. 28 (2) , 239
Open AccessRe: Adherence to NICE guidelines for new glaucoma referrals